US OptionsDetailed Quotes
RIGL241220P22000
- 0.24
- 0.000.00%
15min DelayClose Dec 13 15:58 ET
0.00High0.00Low
0.24Open0.24Pre Close0 Volume10 Open Interest22.00Strike Price0.00Turnover112.40%IV-15.07%PremiumDec 20, 2024Expiry Date3.09Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8718Delta0.0886Gamma5.86Leverage Ratio-0.0505Theta-0.0021Rho-5.11Eff Leverage0.0044Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet